Norovirus derived immunogenic compositions and methods
US10065994B2 · kind B2 · utility
3Cited by
6References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2015 |
| Grant date | Sep 4, 2018 |
| Priority date | — |
| Expiry date | Nov 19, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/16023
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to chimeric norovirus VP1 proteins containing the S-domain of VP1 of a first norovirus strain and a P-domain that contains at least a portion of the P-domain of VP1 of a second norovirus strain. The invention also relates to nucleic acids that encode the chimeric VP1 proteins, virus-like particles that contain a chimeric norovirus VP1 protein, and to immunogenic compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.